Eli Lilly & Co. (LLY) Tops Q3 EPS by 14c
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $1,235.27 +2.93%
Revenue Growth %: +31.7%
Financial Fact:
Research and development: 1.24B
Today's EPS Names:
EPAC, SAR, KRUS, More
Revenue Growth %: +31.7%
Financial Fact:
Research and development: 1.24B
Today's EPS Names:
EPAC, SAR, KRUS, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q3 EPS of $0.89, $0.14 better than the analyst estimate of $0.75. Revenue for the quarter came in at $4.96 billion versus the consensus estimate of $4.99 billion.
Eli Lilly & Co. sees FY2015 EPS of $3.40-$3.45, versus prior guidance of $3.20-$3.30 and the consensus of $3.28.
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
- Unum Group (UNM) PT Raised to $94 at UBS on Second LTC Deal
- Syra Health names Dr. Cori McMahon as fractional chief medical officer
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
